Registered Nurse in Haines City, FL Accepting Medicare

6 Registered Nurse nurses found. Showing 1 - 6

Inga Jennings, APRN Registered Nurse - Pain Management Medicare: Medicare Enrolled Practice Location: 212 S Dixie Dr, Haines City, FL 33844 Phone: 863-547-0788    Fax: 863-547-0789

Jacquelyn L Jones, RN Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 111 N 11th St, Haines City, FL 33844 Phone: 863-421-3204    Fax: 863-421-3210

Namibia Moreno Cabrera, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 101 S Dixie Dr, Haines City, FL 33844 Phone: 863-216-6595

Mrs. Tiffany L Alston-morgan, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 6499 Polk City Rd, Haines City, FL 33844 Phone: 863-348-2660

Yachira Cruz, Registered Nurse - Home Health Medicare: Not Enrolled in Medicare Practice Location: 2040 Honeybell Ave, Haines City, FL 33844 Phone: 407-530-9842

Susan Natalie Esparza, RN Registered Nurse - Case Management Medicare: Not Enrolled in Medicare Practice Location: 311 Paradise Island Dr, Haines City, FL 33844 Phone: 708-829-5019

News Archive

AudioNova, Amplifon's hearing aid and audiology device drive European wholesale market

According to a new report by iData Research, the leading global authority in medical device and pharmaceutical market research, the retail European hearing aid and audiology device market was valued at over €3.8 billion in 2010, while the wholesale market was valued at almost €1.3 billion The retail market is expected to grow rapidly by 2017 due to aggressive growth strategies among local and international retail chains and the adoption of new technologies such as wireless Bluetooth hearing aids and receiver-in-canal models.

Genetic test identifies breast cancer patients that can avoid chemotherapy and remain relapse-free following five years of hormone therapy

Genomic Health has announced the presentation of the first results1 from the Trial Assigning IndividuaLised Options for Treatment (Rx), or TAILORx, a large, prospectively conducted trial designed and conducted by the ECOG-ACRIN Cancer Research Group under the sponsorship of the U.S. National Cancer Institute (NCI).

Shandong Taibang Biological Products earns GMP certification for new production facility

China Biologic Products, Inc., a leading fully integrated plasma-based biopharmaceutical company in China, today announced that its majority-owned subsidiary, Shandong Taibang Biological Products Co. Ltd., has received Good Manufacturing Practices ("GMP") certification from the China Food and Drug Administration (the "CFDA") for its new coagulation factor production facility.

New experimental study shows immunotherapy can reduce acute effects of heroin

Immunotherapy could have a place in the treatment of substance abuse in the future. A specific antibody can reduce the acute effects of heroin, according to a new experimental study at the Norwegian Institute of Public Health.

Read more Medical News

› Verified 5 days ago